Explore NPR1 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Guanylyl cyclases, catalyzing the production of cGMP from GTP, are classified as soluble and membrane forms (Garbers and Lowe, 1994 [PubMed 7982997]). The membrane guanylyl cyclases, often termed guanylyl cyclases A through F, form a family of cell-surface receptors with a similar topographic structure: an extracellular ligand-binding domain, a single membrane-spanning domain, and an intracellular region that contains a protein kinase-like domain and a cyclase catalytic domain. GC-A and GC-B function as receptors for natriuretic peptides; they are also referred to as atrial natriuretic peptide receptor A (NPR1) and type B (NPR2; MIM 108961). Also see NPR3 (MIM 108962), which encodes a protein with only the ligand-binding transmembrane and 37-amino acid cytoplasmic domains. NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP (MIM 108780) and BNP (MIM 600295), respectively).[supplied by OMIM, May 2009]
| Target ID |
GM-T71230
|
| Target Name |
NPR1
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
4881
|
| Gene ID |
100061959 (Equus caballus), 101080682 (Felis catus), 18160 (Mus musculus), 24603 (Rattus norvegicus) 4881 (Homo sapiens), 490455 (Canis lupus familiaris), 533048 (Bos taurus), 715598 (Macaca mulatta)
|
| Target Alternative Names |
ANPR-A,ANPRA,ANPa,Anpra,Atrial natriuretic peptide receptor 1,Atrial natriuretic peptide receptor type A (ANP-A,GC-A,GUC2A,GUCY2A,Gca,Guanylate cyclase A (GC-A),NPR-A,NPR-A),NPR1,NPRA,Npr1,Npra,Pndr
|
| Uniprot Accession |
P18293,P18910,P16066
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease from KEGG |
Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Vascular smooth muscle contraction, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Aldosterone synthesis and secretion
|
| Gene Ensembl |
ENSECAG00000000954, ENSMUSG00000027931, ENSG00000169418, ENSCAFG00845001483, ENSBTAG00000006234, ENSMMUG00000008153
|
| Target Classification |
Pathway
|
NPR1 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo4881 | Pre-made Human NPR1/ANPa/NPRA siRNA oligo Duplex | 4881 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo24603 | Pre-made Rat Npr1/Gca/Npra siRNA oligo Duplex | 24603 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo18160 | Pre-made Mouse Npr1/GC-A/NPRA siRNA oligo Duplex | 18160 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo715598 | Pre-made Cynomolgus/Rhesus macaque NPR1 siRNA oligo Duplex | 715598 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101080682 | Pre-made Cat/Feline NPR1 siRNA oligo Duplex | 101080682 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo490455 | Pre-made Dog/Canine NPR1 siRNA oligo Duplex | 490455 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo533048 | Pre-made Bovines/Cattle NPR1 siRNA oligo Duplex | 533048 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100061959 | Pre-made Equine/Horse NPR1 siRNA oligo Duplex | 100061959 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
NPR1 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T71230-Ab | Human | Anti-Human NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T71230-Ab | Rat | Anti-Rat NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T71230-Ab | Mouse | Anti-Mouse NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T71230-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T71230-Ab | Cat/Feline | Anti-Cat/Feline NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T71230-Ab | Dog/Canine | Anti-Dog/Canine NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T71230-Ab | Bovines/Cattle | Anti-Bovines/Cattle NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T71230-Ab | Equine/Horse | Anti-Equine/Horse NPR1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
NPR1 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T71230-Ag | Human | Human NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T71230-Ag | Rat | Rat NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T71230-Ag | Mouse | Mouse NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T71230-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T71230-Ag | Cat/Feline | Cat/Feline NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T71230-Ag | Dog/Canine | Dog/Canine NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T71230-Ag | Bovines/Cattle | Bovines/Cattle NPR1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T71230-Ag | Equine/Horse | Equine/Horse NPR1 VLP (virus-like particle) | HEK293 | Products Developing |